A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children

Conditions: Myopia Interventions: Device: Bausch + Lomb (kalifilcon A) Myopia Control Soft (Hydrophilic); Device: CooperVision MiSight (omafilcon A/60%) Myopia Control one day Soft Contact Lens Sponsors: Bausch& Lomb Incorporated Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials